Anderman Todd Insider Trades & Stock Holdings

Chief Legal Officer · Ocular Therapeutix, Inc. · Latest filing Oct 8, 2026

Anderman Todd, Chief Legal Officer at Ocular Therapeutix, Inc. has 1 Form 4 trade on file since Oct 8, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($87.36K), net -$87.36K. Latest filing: disposed of 11.98K shares of $OCUL on Oct 8, 2026 at $7.29.

Trades on file

1

Open-market bought

$0

Open-market sold

$87.36K

Net open-market

-$87.36K

Latest filing

Oct 8, 2026

All insider trades by Anderman Todd

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 8, 2026	$OCUL	Sell (Open-market sale) 10b5-1	11.98K	$7.29	$87.36K			-1.7%			Chief Legal Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Anderman Todd traded

• $OCUL

Frequently asked questions

Has Anderman Todd been buying or selling stock?

Anderman Todd has 0 open-market purchases and 1 open-market sale on file, net -$87.36K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Anderman Todd's latest insider trade?

disposed of 11.98K shares of $OCUL on Oct 8, 2026 at $7.29.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.